Humacyte Inc (HUMA): Next-Year EPS Estimate 41.47%
As of 2026-05-28, Humacyte Inc (HUMA) has a next-year EPS growth estimate of 41.47%.
On 2026-05-17, analyst consensus for HUMA's next-year EPS growth shifted from 42.14% to 41.47% — a negative change of 0.67 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at -43.24%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 41.47%
- EPS growth this year
- -43.24%
- EPS next quarter (est)
- -$0.11
- Last price
- $1.28
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-28 | 41.47% | -43.24% | -$0.11 | $1.28 |
| 2026-05-27 | 41.47% | -43.24% | -$0.11 | $1.15 |
| 2026-05-26 | 41.47% | -43.24% | -$0.11 | $1.11 |
| 2026-05-25 | 41.47% | -43.24% | -$0.11 | $1.05 |
| 2026-05-24 | 41.47% | -43.24% | -$0.11 | $1.05 |
| 2026-05-21 | 41.47% | -43.24% | -$0.11 | $1.02 |
| 2026-05-20 | 41.47% | -43.24% | -$0.11 | $0.92 |
| 2026-05-19 | 41.47% | -43.24% | -$0.11 | $0.83 |
| 2026-05-18 | 41.47% | -43.24% | -$0.11 | $0.90 |
| 2026-05-17 | 41.47% | -43.24% | -$0.11 | $0.93 |
| 2026-05-14 | 42.14% | -40.11% | -$0.10 | $1.00 |
| 2026-05-13 | 41.66% | -58.96% | -$0.11 | $1.17 |
| 2026-05-12 | 47.43% | -66.65% | -$0.12 | $0.91 |
| 2026-05-11 | 47.43% | -66.65% | -$0.12 | $1.00 |
| 2026-05-10 | 47.43% | -66.65% | -$0.12 | $1.06 |
| 2026-05-07 | 47.43% | -66.65% | -$0.12 | $1.08 |
| 2026-05-06 | 47.43% | -66.65% | -$0.12 | $0.98 |
| 2026-05-05 | 47.43% | -66.65% | -$0.12 | $0.90 |
| 2026-05-04 | 47.43% | -66.65% | -$0.12 | $0.92 |
| 2026-05-03 | 47.43% | -66.65% | -$0.12 | $0.86 |
| 2026-04-30 | 47.43% | -66.65% | -$0.12 | $0.84 |
| 2026-04-29 | 47.43% | -66.65% | -$0.12 | $0.82 |
| 2026-04-28 | 47.25% | -66.48% | -$0.12 | $0.85 |
| 2026-04-27 | 47.19% | -66.31% | -$0.12 | $0.81 |
| 2026-04-26 | 47.19% | -66.31% | -$0.12 | $0.70 |
| 2026-04-24 | 47.19% | -66.31% | -$0.12 | $0.70 |
| 2026-04-23 | 47.19% | -66.31% | -$0.12 | $0.71 |
| 2026-04-22 | 47.19% | -66.31% | -$0.12 | $0.70 |
| 2026-04-21 | 47.19% | -66.31% | -$0.12 | $0.66 |
| 2026-04-20 | 47.37% | -66.31% | -$0.12 | $0.69 |
Recent News
- Humacyte Inc (HUMA) Q1 2026 Earnings Call Highlights: Sales Surge and Strategic Expansions Amid ...GuruFocus.com
- Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business UpdateGlobeNewswire
- Humacyte Inc (HUMA) Q4 2025 Earnings Report Preview: What To Look ForGuruFocus.com
- Humacyte Appoints Rick McElheny as Senior Vice President of Business DevelopmentGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Humacyte Inc's next-year EPS growth estimate?▾
As of 2026-05-28, Humacyte Inc (HUMA) has a next-year EPS growth estimate of 41.47%, based on analyst consensus.
When was the latest EPS estimate revision for HUMA?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 42.14% to 41.47%.
What sector and industry does Humacyte Inc belong to?▾
Humacyte Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HUMA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Humacyte Inc (HUMA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports